ArticleCurrent oncology (Toronto, Ont.)2022

Immune Effective Score as a Predictor of Response to Neoadjuvant Trastuzumab Therapy and a Prognostic Indicator for HER2-Positive Breast Cancer.

Xueying Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.